no title

Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/..

In this review, we discuss a new definition and treatment options of allergic alveolitis (AA). AA is an immune-mediated interstitial lung disease triggered by inhaled antigens, it is defined as non-fibrotic (inflammatory) and/or fibrotic, and diagnosis relies on a multidisciplinary approach using clinical, radiological and sometimes histological assessments. Treatment involves early antigen elimination and may include corticosteroids or other immunosuppressants. Prognosis varies from reversible inflammation to irreversible fibrosis. Early detection is crucial for better outcomes.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:186

Enthalten in:

Ugeskrift for laeger - 186(2024), 14 vom: 01. Apr.

Sprache:

Dänisch

Weiterer Titel:

A new definition and treatment options of allergic alveolitis

Beteiligte Personen:

Østergård, Nanna Makholm [VerfasserIn]
Møller, Janne [VerfasserIn]
Kronborg-White, Sissel [VerfasserIn]
Prior, Thomas Skovhus [VerfasserIn]
Kølner-Augustson, Line [VerfasserIn]
Iversen, Inge Brosbøl [VerfasserIn]
Kolstad, Henrik [VerfasserIn]
Bendstrup, Elisabeth [VerfasserIn]

Links:

Volltext

Themen:

Adrenal Cortex Hormones
English Abstract
Immunosuppressive Agents
Journal Article
Review

Anmerkungen:

Date Completed 15.04.2024

Date Revised 15.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.61409/V11230705

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370960238